Amanote Research

Amanote Research

    RegisterSign In

Reduced Toxicity Breast Cancer Therapy: Changing the or to and in Dual Targeted Therapeutics

doi 10.21236/ada552005
Full Text
Open PDF
Abstract

Available in full text

Date

October 1, 2010

Authors
Rebekah Drezek
Publisher

Defense Technical Information Center


Related search

Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

CXCR4-targeted Therapy in Breast Cancer

The Lancet Oncology
Oncology
2018English

Bone Marrow Endothelium-Targeted Therapeutics for Metastatic Breast Cancer

Journal of Controlled Release
Pharmaceutical Science
2014English

Targeted Therapy for Breast Cancer Prevention

Frontiers in Oncology
Cancer ResearchOncology
2013English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Cancer Targeted Therapeutics: From Molecules to Drug Delivery Vehicles

Journal of Controlled Release
Pharmaceutical Science
2015English

Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics

Journal of Ovarian Research
GynecologyOncologyObstetrics
2010English

Nanoparticle-Based Targeted Therapeutics in Head-And-Neck Cancer

International Journal of Medical Sciences
Medicine
2015English

Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics

Pediatric Clinics of North America
Child HealthPediatricsPerinatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy